Please login to continue



Adnews offers non-subscribers free access to one story per month.

Subscribe for unrestricted access to our content.

Forgot your login or password? Click here.

Shannon joins Valeant Pharmaceuticals

Valeant Pharmaceuticals of Laval, QC has appointed Arthur Shannon to the position of senior vice-president, and head of communications and investor relations. Shannon was most recently vice-president of global corporate affairs and European investor relations at Perrigo. Prior to that, he held a series of investor relations positions at Thomson Financial and Dynegy.

« Back Next »

Related stories Comments